Home  /  Investors   /  Press releases

Press releases

Here you will find all press releases from XVIVO.

Showing 1 to 30 out of 33 posts.
1 Dec, 2020
First patient in the European Heart Preservation study transplanted
20 Nov, 2020
Publication in The Lancet shows better survival of transplanted kidneys after cold machine perfusion with oxygen
23 Oct, 2020
First in the world with products for all major solid organs
16 Oct, 2020
Conference call on Interim Report
14 Oct, 2020
Report from Extraordinary General Meeting in XVIVO Perfusion
1 Oct, 2020
XVIVO Perfusion completes the acquisition of Organ Assist B.V.
30 Sep, 2020
Nomination committee of XVIVO Perfusion AB (publ)
30 Sep, 2020
Increased number of shares and votes in XVIVO Perfusion AB (publ)
24 Sep, 2020
XVIVO Perfusion’s warrant program 2020/2022
23 Sep, 2020
XVIVO Perfusion has carried out a directed share issue of 2,118,640 shares at a subscription price of SEK 236 per share
23 Sep, 2020
XVIVO Perfusion intends to carry out a directed issue of shares
23 Sep, 2020
XVIVO Perfusion to acquire the Dutch medtech company Organ Assist and finances the acquisition through a private placement of new shares
21 Sep, 2020
Changes in XVIVO Perfusion’s Management Team
11 Sep, 2020
Notice to attend the Extraordinary General Meeting in XVIVO Perfusion AB (publ)
9 Sep, 2020
First patient in the PrimECC study included
4 Sep, 2020
XVIVO Perfusion strengthens the management team with the addition of a new Commercial Director and R&D Director
10 Jul, 2020
In the starting blocks for heart preservation and PrimECC trial
2 Jul, 2020
Conference call on Interim Report
12 Jun, 2020
The study from Lund published in Nature Communications
28 Apr, 2020
Magnus Nilsson hands over the baton to Dag Andersson as President and CEO of XVIVO Perfusion
9 Apr, 2020
Strong cash flow despite the influence of Covid-19
6 Apr, 2020
Conference call on Interim Report (link updated)
31 Mar, 2020
Report from Annual general meeting of XVIVO Perfusion AB (publ)
31 Mar, 2020
XPS™ sold to pediatric transplantation clinic in Italy
25 Mar, 2020
The Nomination Committee proposes unchanged Board remuneration -adjusted version
25 Mar, 2020
The Nomination Committee proposes unchanged Board remuneration
25 Mar, 2020
XVIVO Perfusion advances the date for submission of the January-March 2020 interim report
18 Mar, 2020
As a result of Covid-19: The Annual General Meeting of XVIVO Perfusion is moved to a new address and further precautions are taken
18 Mar, 2020
THE COVID-19 EFFECT ON XVIVO PERFUSION
9 Mar, 2020
Annual Report 2019

Fill out the form to watch the video